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ReviewPolybacterial diseases involve multiple organisms that
act collectively to facilitate disease progression. Al-
though this phenomenon was highlighted early in the
20th century, recent technological advances in diagnos-
tics have led to the appreciation that many infections are
far more complex than originally believed. Furthermore,
it is apparent that although most treatments focus on
the dominant bacterial species in an infection, other
microbes, including commensals, can have a profound
impact on both the response to therapy and virulence.
Very little is known about the molecular mechanisms
that underpin interactions between bacteria during such
infections. Here, we discuss recent studies identifying
and characterizing mechanisms of bacterial interaction
and the biological processes they govern during certain
diseases. We also highlight how possible strategies for
targeting these interbacterial interactions may afford a
route towards development of new therapies, with con-
sequences for disease control.
A growing appreciation for the polymicrobial nature of
infections
The earliest examination of human infection sites using
rudimentary microscopic methods revealed the coloniza-
tion of multiple bacterial species [1,2]. Despite this obser-
vation, the possibility that infections may be polymicrobial
in nature was generally overlooked for many years. Poten-
tial interest in the topic was further stifled by the belief
that disease was mediated by a single virulence factor
produced by the dominant organism. Although this is true
for some infections, immunization against single virulence
factors has proven unsuccessful in many situations, sug-
gesting far greater complexity than initially envisaged. We
now appreciate that bacterial virulence is multifactorial
and that the majority of infections result from colonization
by more than one microbe [1,2].
This re-evaluation has been driven in recent years by
the improvement of diagnostic and genomic technologies;
characterization of bacteria associated with many infec-
tions including chronic wounds, otitis media, and respira-
tory tract infections has revealed the presence of specific
combinations of species (Table 1). Furthermore, other0966-842X/
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by single bacterial species have now been shown to be
associated with a considerably more diverse bacterial pop-
ulation (Table 1). These findings have prompted a substan-
tial effort aimed at understanding the nature of
polymicrobial disease that is reflected in the escalation
in publications on the topic, which have trebled in the past
5 years. This focus is certainly timely, given the health care
and other socio-economic costs associated with many of
these diseases and their treatment (Table 1).
Recent microbial community surveys of infections have
provided extensive information about microbiota diversity,
gene content, and potential functions. There is as yet less
understanding of the metabolic activities of these diverse
organisms during the infection process and the molecular
mechanisms that underpin interspecies interactions. A
number of in vitro studies have given insight into inter-
species interactions. This body of work suggests that a
variety of molecules are exchanged between bacteria, en-
abling various competitive, synergistic, or neutral relation-
ships to be conducted. More recently, physical contact
between bacteria has been implicated in modulation of
microbial behavior. Extrapolations of the findings from
in vitro systems to the disease state need to be made
cautiously of course. Nevertheless, both the detection of
molecules during infection by metabolome analysis and
mutational analysis of bacteria in model polymicrobial
infections provide experimental support for some of the
conclusions drawn. Here, we discuss the major types of
interbacterial interaction that may govern disease, high-
light recent advances in our understanding of interbacter-
ial interactions in vivo, and discuss potential implications
of targeting these interactions as a route towards control of
bacterial disease. Interactions between bacteria and virus-
es, or bacteria and fungi, are also known to be important in
several disease settings. We will focus on bacterial–bacte-
rial interactions, but direct the reader to several recent
reviews addressing other aspects of polymicrobial infec-
tions including interkingdom interactions [1–4].
Exchange of chemicals between bacteria during disease
Bacteria produce many types of diffusible molecules that
can affect their neighbors in different ways (Figure 1).
Bacteria of the same species often use signal molecules
to monitor aspects of their environment such as population
density (a process that has been termed quorum sensing)
and to modulate their behavior accordingly. Molecules are
generally classed as ‘signals’ if they are produced by a
dedicated pathway at a specific stage of growth, and elicit
Table 1. Examples of polybacterial human diseases and the consequences of bacterial interactiona
Disease Dominant bacteria Consequences of co-infection; likely
interbacterial interactions
Healthcare
costs
Refs
Cystic fibrosis
lung
Pseudomonas aeruginosa,
Staphylococcus aureus, Haemophilus
influenzae, Burkholderia cepacia
complex, Stenotrophis maltophila
Increased antimicrobial tolerance, biofilm
development, and biomass; metabolite
perception, AI-2 and DSF-mediated
signaling
$49 000 per
patient per
year USD
[15,29,
62,63]
Device-related
infections
S. aureus, Staphylococcus epidermidis,
Staphylococcus haemolyticus, Proteus
mirabilis, Providencia stuartii
Co-infection promotes progression to
bacteremia; mixed biofilm formation
$2.3 billion USD [64,65]
Urinary tract
infection
Escherichia coli (UPEC), Staphylococcus
saprophyticus, Group B Streptococcus,
Enterococcus faecalis, Klebsiella sp.,
Enterobacter sp., Proteus sp.
More persistent infection; modulation of
host immunity by non-pathogen
promotes infection by pathogen
$1.6 billion USD [66,67]
Pneumonia Streptococcus pneumoniae, H. influenza Increased biofilm formation and
colonization of nasopharynx
$7.4 billion USD
(Medicare only)
[68,69]
Otitis media H. influenzae, S. pneumoniae, Moraxella
catarrhalis
Increase in biofilm, colonization of
nasopharynx, antibiotic resistance and
persistence of the infection; mixed biofilm
formation and AI-2 signaling implicated
$2.88 billion USD [9,10,70]
Periodontitis Porphyromonas gingivalis, Treponema
denticola, Veillonella atypica,
Fusobacterium nucleatum,
Streptococcus sp., Aggregatobacter
actinomycetemcomitans
Biofilm formation, persistent infection and
chronic inflammation; metabolite
exchange, co-aggregation, interspecies
signaling
£2.7 billion
(UK, NHS)
[1,22,26,
66,71–73]
Wound infections
and diabetic
ulcers
S. aureus, P. aeruginosa, Enterococcus
sp., Bacteriodes fragilis,
Corynebacterium sp.
Delayed wound healing, resistance to
antibiotics; biofilm formation,
peptidoglycan sensing, modulation of
host immunity
Diabetic foot
ulcers: $9–13 billion
USD
[21,74–77]
Inflammatory bowel
disease
Correlated with presence of adherent-
invasive E. coli, Fusobacterium sp.,
increase in Gammaproteobacteria and
reduction in Firmicutes, Clostridium sp.
and Bifidobacterium species
Direct interbacterial interactions
unknown, immune modulation by one
species may promote or suppress growth
of another speciesb
Unknown [78,79]
aAbbreviations: NHS, National Health Service; UPEC, uropathogenic E. coli; USD, US dollar.
bIn a mouse model of colitis, prior infection by Helicobacter pylori was shown to reduce inflammation caused by subsequent infection with Salmonella Typhimurium
through modulation of host immunity.
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those required for the processing of the molecule. Such
effects usually occur following perception by a specific
receptor and act to benefit both producer and receiver.
The signal molecules synthesized by bacteria belong to a
wide range of chemical classes and diverse mechanisms for
signal perception and transduction have been described
[5,6]. Some types of signal molecules produced for intracel-
lular signaling can be recognized and influence other non-
producing species through ‘eavesdropping’ [5,6]. Other
interspecies interactions range from the symbiotic, such
as the cross-feeding of intermediary metabolites during the
enzymatic breakdown of complex carbon sources, to the
strictly antagonistic, such as the production of lethal quan-
tities of antibiotics or bacteriocins. Interactions can benefit
one partner while the other is unaffected (where the mole-
cules involved are termed ‘cues’) or allow subtle, non-lethal
manipulation of the other species for the benefit of the
producer (termed ‘coercion’). Many of these chemical inter-
actions are contingent on the close proximity of bacteria,
which can result from physical interactions such as forma-
tion of mixed biofilms (discussed below).
Interspecies communication through diffusible signals
As outlined above, bacteria can sense signal molecules
produced by other bacteria in their immediate environmentduring disease. We will illustrate this facet of interspecies
communication in the context of mixed infections through
consideration of autoinducer-2 (AI-2) and signals of the
diffusible signal factor (DSF) family. It should be noted that
other types of signal molecule including N-acyl homoserine
lactones (AHLs), Pseudomonas quinolone signal (PQS), and
4-hydroxy-2-heptylquinoline-N-oxide (HQNO) have been
found to be produced during infection and to influence other
bacteria through eavesdropping [5,6].
AI-2
AI-2 is a ribose-derived signal molecule produced and
perceived by multiple different bacteria [7]. The enzyme
responsible for AI-2 synthesis is LuxS, which is also in-
volved in central metabolism through a pathway responsi-
ble for recycling S-adenosyl methionine. AI-2 acts as an
intraspecies quorum sensing signal in a number of Gram-
positive and Gram-negative bacteria, where it influences
biofilm formation and production of various virulence fac-
tors [8]. AI-2 may not have a role in quorum sensing in all
bacteria but may nevertheless be secreted, because it can
be toxic to cells. Studies of bacteria associated with otitis
media have revealed synergy between the luxS-deficient
species Moraxella catarrhalis and the AI-2 producers Hae-
mophilus influenzae and Streptococcus pneumoniae [9,10].
AI-2 synthesis by H. influenzae promotes mixed biofilm509
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Figure 1. Schematic illustrating potential bacterial interspecies interactions. Bacteria can influence other cells in a community through both chemical (top) and physical
interactions (bottom). Chemical interactions include the production and perception of specific signal molecules such as diffusible signal factor (DSF) and autoinducer-2 (AI-
2), which benefit both the producer and the receiver strain. The cross-feeding of metabolites between members of a community allows growth on complex carbon sources,
and can also elicit responses distinct from metabolism, as a means of surveying the bacterial community. H2O2 and peptidoglycan are two examples of interspecies cues
that elicit beneficial responses in the receiving species. Physical interactions between cells include those involved in formation of biofilms, which protect cells from stresses
such as antibiotics and host immunity. Formation of mixed-species biofilms involves receptor and adhesin-mediated co-aggregation, interaction of other surface
appendages such as pili and fimbriae, and the regulated secretion of an extracellular matrix in which surface structures become embedded. Contact-dependent interactions
can also be antagonistic, as seen with type VI secretion in which toxins are translocated into neighboring cells.
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infection in chinchillas [9], whereas AI-2 synthesis by S.
pneumoniae increases M. catarrhalis colonization of the
nasopharynx in co-infection of mice or chinchillas [10].
Interestingly, AI-2 alters the course of S. pneumoniae
and M. catarrhalis co-infections in vivo but does not affect
mixed biofilm formation in vitro [10]. Such findings high-
light the need for both animal model studies and in vitro
experiments to fully explore the consequences of different
types of interaction (Box 1).
AI-2 signaling may also influence the virulence of Pseu-
domonas aeruginosa in the cystic fibrosis (CF) lung. AI-2 is
produced by certain bacteria found in CF sputum, such as
Staphylococcus and Streptococcus species that are members
of the oropharyngeal flora, but not by P. aeruginosa. Co-
culture with either of two different AI-2 producing strains of
Staphylococcus and Streptococcus species was shown to
increase damage caused by P. aeruginosa in rat lung
infections. Furthermore, CF sputum contains AI-2 at suffi-
cient levels to alter P. aeruginosa gene expression in vitro,510supporting the idea that interspecies AI-2 signaling is a
contributing factor in the course of pathogenesis in CF [11].
DSF
DSF family signals are fatty acid molecules that share a
characteristic cis-unsaturated double bond at position two
of the fatty acid chain [12]. DSF was discovered in the plant
pathogen Xanthomonas campestris but has since been
shown to be produced by several clinically relevant bacte-
ria including Stenotrophomonas maltophilia and Burkhol-
deria species. Interspecies DSF signaling is implicated in
CF lung infections involving P. aeruginosa, Burkholderia
cenocepacia, and S. maltophilia. P. aeruginosa responds to
DSF (cis-11-methyl-2-decenoic acid) produced by S. mal-
tophilia and the related molecule BDSF (cis-2-dodecenoic
acid) from B. cenocepacia, although it does not synthesize
either of these molecules. Exposure of P. aeruginosa to DSF
alters biofilm formation and polymyxin tolerance [13],
whereas BDSF causes a modest decrease in quorum sens-
ing signal production and type III secretion [14]. A recent
Box 1. Reconstruction of polybacterial infections using in
vivo models
Studies using in vivo models that closely mimic features of human
polybacterial diseases are key in bridging the gap from the lab to the
clinic. Modeling polybacterial infections presents specific challenges
such as establishing a mixed infection and, in some cases, managing
the effects of the native microbiota. When choosing an in vivo model
it is important to know how closely the model infection reflects
aspects of the human disease such as colonization, chronic infection,
and interaction of the pathogen(s) with the immune system. Practical
issues must also be taken into account, such as cost, ethics,
manipulability, and options for controlling the native flora.
Several invertebrate models have already been used to examine
interbacterial interactions that contribute to virulence, as well as
some features of the innate immune response. Their ease of use
makes them suited for high throughput experiments. For example,
experiments using the fruit fly Drosophila melanogaster and the
pathogen P. aeruginosa were used to demonstrate the virulence-
enhancing effects of a subset of oropharangeal commensal organ-
isms [80] and of peptidoglycan from Gram-positive bacteria [21].
Studies in mammals are needed when the research question
requires reconstruction of more specific features of a disease, such
as persistent infection or colonization of a specific organ. Different
mammalian models offer distinct advantages and disadvantages in
how accurately they represent the human disease and the degree of
control they offer the scientist. For example, bacterial periodontitis
can be modeled in the oral cavity of antibiotic-treated rats or in
mouse skin wound infections. Although the former model is a closer
representation of the disease, the wound infection model is easier to
administer and monitor. It is also easier to exclude other bacteria in
this model. Both models have been useful in revealing some of the
interbacterial interactions that influence this disease [26,81].
Developing accurate animal models of CF lung infection has been
challenging. Various CFTR (cystic fibrosis transmembrane conduc-
tance regulator) mutant mice are available, however, these do not
develop the chronic infections that characterize the human disease
[82]. Chronic infection is mimicked by implanting agar beads with
embedded bacteria directly into mouse or rat lungs, and this model
has been used to investigate the synergy of P. aeruginosa with other
CF pathogens [29]. New models in CFTR mutant pigs and ferrets
may offer more options for modeling the development and
progression of chronic CF lung infection [83].
Advances in sequencing and metabolomics approaches have
made it possible to observe the events of human infections in detail.
It is likely that these will be deployed in in vivo models to improve
the resolution of our understanding of these infections.
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lines of evidence supporting the contention that DSF fami-
ly signaling contributes to P. aeruginosa persistence and
antibiotic resistance in CF lung infection. Specifically, DSF
and BDSF are both found at physiologically relevant levels
in CF sputum from adult patients, where their presence is
correlated with B. cenocepacia and S. maltophilia coloni-
zation. Furthermore, DSF treatment increases the persis-
tence of P. aeruginosa in a mouse model of CF lung
infection. Together, these data provide evidence that in-
terspecies DSF-mediated bacterial interactions occur in
the CF lung and may influence the efficacy of antibiotic
treatment.
Antibiotics, indole, and other cues
Bacteria can also respond to their neighbors in ways that
fall outside strict definitions of either signaling or metabo-
lite exchange (which we will examine below). A number of
bacteria produce antibiotic compounds that may have a
role in competition for niches or resources. Antibiotics atsub-lethal concentrations can alter the behavior of some
clinically-relevant bacteria in ways that promote survival
or infection [16]. For example, treatment of Staphylococcus
aureus with beta-lactam antibiotics promotes biofilm for-
mation [17]. Many bacteria produce the metabolite indole,
which can modulate the virulence of some bacterial patho-
gens that do not produce the molecule [18]. For example,
indole suppresses P. aeruginosa virulence through inter-
ference with AHL quorum sensing [19], and also sup-
presses virulence of S. aureus, where it acts to repress
the expression of several virulence factors including a-
hemolysin and enterotoxin [20]. Finally, peptidoglycan
and hydrogen peroxide can function as interspecies cues.
P. aeruginosa senses peptidoglycan from Gram-positive
bacteria through a specific two-component system recep-
tor; this triggers enhanced virulence and killing of Gram-
positive commensals [21]. Hydrogen peroxide, which is
produced by oral streptococci such as Streptococcus gordo-
nii during fermentation of sugars, induces increased resis-
tance to host innate immunity in the periodontitis-causing
bacterium Aggregatibacter actinomycetemcomitans [22].
Metabolite cross-feeding
In addition to antagonistic interactions, different species of
bacteria can also act in a cooperative fashion through
metabolite cross-feeding, where one species utilizes an
end-product of a metabolic pathway of another species.
The metabolic abilities of the different bacteria in the
community thereby complement each other. Nutritional
cooperation is especially well-documented in the oral bac-
teria, and has been demonstrated for pairs of bacteria
[17,18], as well as certain consortia such as the set of five
species from dental plaque that collectively degrade the
salivary mucin glycoprotein MUC5B [23,24]. Metabolic
relationships can be coupled to other types of communica-
tion, sometimes in a reciprocal fashion. An example of this
is the mixed biofilm formed by Veillonella atypica and S.
gordonii, in which V. atypica consumes lactate produced by
S. gordonii, which itself produces amylase in response to a
diffusible molecule from V. atypica [25].
Cross-feeding has consequences beyond supporting the
growth of bacteria with limited metabolic capacities. Re-
cently, some bacteria have been shown to preferentially
consume the fermentation products of neighboring bacte-
ria when faced with a choice of carbon sources. The choice
of a ‘social’ carbon source has downstream effects on
growth and virulence. A. actinomycetemcomitans shows
better colonization and greater pathogenesis in mouse
abscess infection when co-cultured with S. gordonii, and
this advantage is dependent on its ability to metabolize
lactate produced by S. gordonii [26]. In this case, cross-
feeding appears to benefit A. actinomycetemcomitans by
precluding nutrient competition with faster-growing resi-
dent streptococci at an early stage, allowing it to persist
and cause infection later. The opportunistic pathogen P.
aeruginosa also shows altered virulence phenotypes when
grown on fermentation products produced by many of the
bacteria that reside with P. aeruginosa in the CF airway, in
comparison to glucose. P. aeruginosa grown on 2,3-buta-
nediol shows increased biofilm formation, virulence factor
production, and antimicrobial activity against various511
Review Trends in Microbiology September 2014, Vol. 22, No. 9bacteria [27]. Thus, even though it is not necessary from a
metabolic perspective, surveillance of the metabolites in
the environment allows P. aeruginosa to assess which
bacteria are co-residents and alter its behavior and life-
style accordingly. The emergence of new metabolomics
technologies has made it possible to explore the breadth
and importance of metabolic interactions in polymicrobial
infections by directly characterizing the content of infec-
tion sites (discussed further below).
Contact-dependent interactions between bacteria
during infection
Although interactions between bacteria mediated by dif-
fusible chemicals have received the bulk of attention,
contact-dependent interactions are gaining increasing in-
terest. Many insights into contact-dependent signaling
have come from the study of biofilm formation, where
physical interactions have been demonstrated to modulate
community growth and behavior (Figure 1). In addition,
the consequences of physical interaction are very different
in polybacterial infections compared to single-strain mod-
els, suggesting that these interactions play a key role in
enabling bacteria to adopt a polybacterial lifestyle.
Lessons from mixed-species biofilm infections
Biofilms are surface-attached bacterial communities, em-
bedded in a matrix, which show radically different proper-
ties compared to free-living bacterial cultures. Studies of
chronic clinical infections using in vivo and in vitro models
have highlighted significant impacts of mixed-species bio-
films in a range of chronic infections such as otitis media,
wound infections, and CF lung infections (Table 1). In
mixed-species biofilms, synergistic interactions often occur
and result in beneficial effects such as greater biofilm
biomass and enhanced antibiotic tolerance [10,28,29]. Pili
and fimbriae, which are hair-like adhesive structures on
the bacterial cell surface, play a critical role in cell–cell
interactions during mixed-species biofilm formation
[30,31]. In addition, flagella have been shown to be impor-
tant for the initial surface attachment of bacteria including
Escherichia coli, Vibrio cholera, and P. aeruginosa during
infection [31–33]. Co-aggregation, the adhesion of geneti-
cally distinct bacteria to each other, is a process that has
been most extensively investigated in oral polymicrobial
biofilm formation. Oral biofilm formation occurs in an
ordered, sequential process with the attachment of each
bacterial species acting as a scaffold for the attachment of a
subsequent species. Interactions are highly specific be-
tween pairs of bacterial species and are mediated by an
adhesin on one cell type binding to a complementary
receptor on another [34,35].
Interbacterial physical interactions can also promote
disease in ways that are independent of biofilm forma-
tion. Recent studies of enteric and oral pathogens have
shown that co-aggregation of infecting bacteria promotes
adherence to and invasion of eukaryotic cells [36,37].
Furthermore, physical interactions between co-infecting
bacteria such as S. pneumoniae and H. influenzae have
also been shown to result in altered virulence factor
expression to promote colonization of an environmental
niche [38].512Do other physical interactions between bacteria
contribute to infection?
Several mechanisms of physical interaction between bac-
terial cells have been described that may play a role during
infection. One of the most recently identified is the type VI
secretion system (T6SS), which mediates interactions be-
tween many Gram-negative bacterial species. The T6SS
was first identified in two human pathogens, V. cholerae
and P. aeruginosa and was initially thought to be involved
in virulence by directly targeting eukaryotic cells [39,40]. It
has subsequently been discovered that most T6SSs actu-
ally mediate interbacterial competition by transporting
toxins directly into competitor bacterial cells, whereas
attacking cells possess cognate immunity proteins to pre-
vent self-intoxication. T6SSs have now been identified in a
vast array of pathogenic bacteria. It is thought that T6SS
could play a role in a polybacterial infection by providing a
competitive advantage for those bacteria with these func-
tions. The antagonistic activity could aid initial coloniza-
tion and enable a pathogen to defend a niche against
invading competitors.
Russel et al. [41] recently hypothesized several non-
antagonistic functions for T6SSs in polybacterial environ-
ments including toxin–immunity complexes that may func-
tion as signaling molecules in immune cells. A role for the
T6SS in enhancing the extracellular matrix in biofilm
populations via toxin-mediated cell lysis was also sug-
gested. The presence of antibacterial T6SSs in bacteria
associated with chronic polymicrobial infections such as P.
aeruginosa, Serratia marcescens, and Burkholderia sp.,
indicates a potential role for the T6SS during infection
[40,42,43]. An important observation in support of this
contention is that CF patients chronically infected with
P. aeruginosa were found to possess antibodies that cross-
react with Hcp1 (a structural protein from the P. aerugi-
nosa antibacterial T6SS-1), suggesting that T6SS is active
in the CF lung and may promote the survival of P. aeru-
ginosa over other bacteria [40].
Other types of contact-dependent interaction are known
to play roles in interbacterial interactions during environ-
mental scenarios. Metal-reducing soil bacteria can express
complex networks of electrically conductive pili known as
nanowires [44], whereas contact-dependent inhibition
through two-partner secretion systems that can deliver
toxins to neighboring cells are encoded by many strains
of pathogenic E. coli as well as many other pathogens [45].
Further work will uncover if these types of interactive
systems play a role during infection.
Profiling and further understanding interbacterial
interactions
Although great strides have been made in developing
animal models to reproduce the etiology of human poly-
microbial diseases (Box 1), these approaches still present
considerable drawbacks and challenges. Complementary
approaches that directly characterize the human infections
are believed to deliver more meaningful insights into
complex microbial infections and their activities. Genomic,
proteomic, and metabolomics tools have been successful in
probing the environment of polymicrobial infection sites.
Whereas metagenomics surveys the metabolic potential
Box 2. Analyzing the polybacterial nature of CF respiratory
infections to inform clinical judgment and treatment
The arrival of high-throughput parallel sequencing technologies has
already revolutionized the study of microbiology within a short
period [84,85]. Several studies have suggested that the throughput
and quality of data being generated by these approaches bring
personalized diagnostics within immediate reach [86,87]. Polymi-
crobial lung disease associated with CF is a well-documented case
where this type of approach may be beneficial [86,87].
Historically, a limited number of bacterial species including
Pseudomonas aeruginosa, Burkholderia cenocepacia, Staphylococ-
cus aureus, and Haemophilus influenzae were established as
important CF pathogens. The ability to routinely identify these
pathogens has for the most part informed antibiotic treatment in
patients with CF presenting with pulmonary exacerbations [85].
However, it has been widely reported that treatment based on
antibiotic susceptibilities of these specific CF pathogens does not
correlate strongly with clinical outcome [88].
The appreciation that CF airway infections are more broadly
polymicrobial than originally thought has offered potential explana-
tions for the sometimes poor response to antibiotic therapy [85,88].
Molecular profiling of the CF-derived sputum has revealed that there
are dozens of bacterial genera present, including Streptococcus and a
variety of anaerobes including Prevotella, Fusobacterium, and Veillo-
nella. Specific bacterial species have been revealed to be colocated in
different regions of the airway [89]. The relative contribution by these
newly identified members and their location within the CF airway to
clinical status, disease progression, and the efficacy of antibiotic
treatment against pathogens remains to be fully examined.
Improved patient outcomes may be achievable with the applica-
tion of more focused antibiotic therapy that is based on compre-
hensive microbiological analyses of each patient. A current EU
funded project CFMATTERS (Cystic Fibrosis Microbiome-deter-
mined Antibiotic Therapy Trial in Exacerbations: Results Stratified)
aims to address this issue through a clinical trial comparing the use
of microbiome-directed antibiotic treatment versus standard ther-
apy (http://www.cfmatters.eu). The analysis should enhance scien-
tific knowledge of the polymicrobial lung disease, based on bacterial
molecular profiling of sputum, allowing the use of stratified targeted
antibacterial therapy that can be compared with standard empirical
antibacterial therapy currently used. If successful the approach may
pave the way for more effective therapeutic regimes and ultimately
contribute to personalized CF treatment and the development of
personalized treatment for other polybacterial diseases.
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microbial community, metatranscriptomics, metaproteo-
mics, and metabolomics provide insights into the current
metabolic activities during infection.
The potential of these tools was illustrated recently by
Lim and colleagues [46], who used metagenomic and meta-
transcriptomic approaches to characterize the bacterial
and viral communities present in the sputum of five CF
patients with chronic lung infections. Each CF patient was
found to possess a unique microbial profile with dominant
infecting organisms persisting over time, although abun-
dances varied during periods of exacerbation or antibiotic
treatment. The metatranscriptome analyses showed the
greatest variation both between patients and over time
[45]. Lim and colleagues considered that this approach was
best able to capture the dynamic nature of these complex
communities [45]. A number of studies have reported
metabolite profiling of sputum from CF patients that
provide insight into the environment of bacterial commu-
nity of the CF airway and alterations in the environment
that occur during exacerbation [47]. These studies high-
light the potential of these technologies to be effective tools
to reveal the varied and dynamic nature of polymicrobial
communities during infection.
New technologies to study metabolic exchange process-
es within polymicrobial communities are also being devel-
oped. For example, Moree and colleagues [48] recently
described the use of matrix-assisted laser desorption ioni-
zation time-of-flight (MALDI-TOF) and MALDI-Fourier
transform-ion cyclotron resonance (MALDI-FT-ICR) imag-
ing mass spectrometry (MALDI-IMS) combined with tan-
dem mass spectrometry (MS/MS) networking to provide
insight into the metabolic interactions between CF lung
pathogens. Using these technologies, they were able to
visualize and identify the metabolites secreted by each
organism and reveal a complex molecular interplay that
involved suppression, increased production, and biotrans-
formation of a range of molecules.
These techniques also allow predictions based upon
studies of monospecies and multispecies communities in
model systems to be tested in a real infection, and they can
reciprocally inform the design of the model experiments so
that the experimental conditions more closely mimic the
infected state. An example of the first point is the assay of
signal molecules in the sputum of CF patients that shows
that they are present at levels that are physiologically
relevant for interspecies signaling, as determined from
model in vitro systems [15]. The second point is illustrated
by the work of Jorth and colleagues [49] who explored the
use of RNA sequencing (RNA-seq) to obtain a high-resolu-
tion transcriptome of A. actinomycetemcomitans during
growth in vitro and in a murine abscess infection. A large
number of metabolic genes were more highly expressed
during infection, including those for formate dehydroge-
nase ( fdhF1F2) and fumarate reductase ( frdABCD), which
are associated with fermentative and anaerobic metabo-
lism, respectively. Overall, this experimental strategy pro-
vides an excellent outline for future investigations of
bacterial physiology during infectious processes, and for
the design of in vitro experiments under appropriate
growth conditions.Understanding interbacterial interactions may improve
therapy
Exploitation of the wealth of metagenomic and metagenetic
data on polybacterial disease is crucial for informed clinical
judgment and appropriate treatment (Box 2). Currently the
preferred treatment strategy for many polybacterial infec-
tions is still the use of broad-spectrum antibiotics [50–53].
Unfortunately such courses of antibiotics are generally
ineffective or fail in many cases [54]. This problem is com-
pounded by the continued emergence and increasing preva-
lence of multiple drug-resistant strains. Thus, alternative
treatments strategies are required. By taking into account
the complement of infecting organisms and the complex
interactions between them, a new approach where therapy
is personalized to each patient could be developed for treat-
ing such infections. Below we discuss some of the approaches
that could be used in combating polybacterial infections and
highlight initial evidence for their clinical potential.
Interference with interbacterial communication
Through work on individual bacterial species, several
strategies have been developed to inhibit or interfere with513
Box 3. Outstanding questions
 How can existing diagnostic tools be improved and new tools be
established to characterize the bacterial communities in poly-
bacterial diseases and to identify the molecules involved in
interspecies interactions?
 Will targeted antibacterial therapy based on bacterial molecular
profiling be more effective than standard empirical antibacterial
therapy?
 Non-pathogenic organisms coexist with pathogens in many sites
of infection. What is the impact of these organisms on the
virulence and antibiotic susceptibility of pathogens?
 The molecular mechanisms that underpin interbacterial interac-
tions during infection remain poorly understood. Will new
mechanisms be uncovered?
 The impact of polybacterial infections on the host immune
response needs to be examined. How will this differ from the
response to individual pathogens?
 Development of biotherapeutics against polybacterial infection
has begun with vaccine and phage therapy. Can an understanding
of interbacterial interactions provide a platform for targeted
interference strategies and improved care?
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lence factor synthesis and gene expression [55,56]. There
are several studies describing small molecules that are
effective in interfering with these processes that were
identified either through screening of chemical libraries
or that are structural analogs of the signal molecules [51].
Other approaches to interfere with signaling have used
enzymes that degrade the signal molecules [55,56]. For
every class of bacterial cell–cell signal discovered thus far,
a mechanism has been discovered that inhibits, destroys,
or removes it. Work on the inhibition of these signaling
systems in single species provides a platform for manipu-
lation of interspecies interactions during polybacterial
disease.
As discussed previously, there is evidence that interspe-
cies signaling with DSF family molecules influences bio-
film formation and increases polymyxin tolerance in P.
aeruginosa, factors that may contribute to the refractory
nature of polymicrobial lung infections to therapy. It
remains to be seen whether interference with DSF signal-
ing during infection may negatively affect P. aeruginosa
persistence. Intriguingly, Deng et al. [57] have recently
demonstrated that treatment with DSF or analogs make
bacterial pathogens including Bacillus cereus and S. aure-
us more susceptible to antibiotic treatment in vitro. The
mechanistic bases for these effects are as yet unknown.
Indole signaling is known to suppress virulence of some
important pathogens and the potential for the therapeutic
use of related molecules is being investigated. Indole deri-
vatives have shown potential as post-biotics, because in-
dole-3-propionic acid is a powerful antioxidant and 7-
hydroxyindole diminishes virulence and colonization of
P. aeruginosa [58]. In order to capitalize on these observa-
tions, screening for more natural and synthetic indole
derivatives that are nontoxic and cannot be easily metab-
olized by other pathogens is now needed, in conjunction
with further in vivo studies.
Disruption of interbacterial contact and attachment
Pili and fimbriae are adhesive surface structures required
for biofilm formation and attachment to both the host and
other bacteria; their loss often results in dramatically
reduced virulence. Chemical targeting of these structures
is being considered as an approach to neutralizing various
infections. This has been exploited in recent efforts to
target uropathogenic E. coli by inhibiting type I pili.
Deploying pilicides (mimics of the normal pilin subunits)
interfered with pilin export, leading to reduced cell aggre-
gation and improved clearance of infection in various in
vivo models [59,60]. Although pilicides have not been
tested specifically in treating a mixed bacterial infection,
effective use in several non-sterile mouse models, which
most likely carry commensals, suggests the potential of
this approach.
Adhesion inhibitors based on synthetic receptor analogs
have also proved to be potent in disrupting adhesion of
many bacteria [61]. For example, synthetic peptides and
glycerophosphate derivatives mimicking fragments of fim-
brial adhesins have been effective against several oral
infection studies of mice [61]. Although these studies pro-
vide evidence of the potential of adhesion inhibitors, the514use of these molecules in their present form is not desirable
owing to their proinflammatory properties and potential
cytotoxicity. Moreover, their potency against polybacterial
infection still needs to be scrutinized using more appropri-
ate in vivo models.
As evidenced in this section, substantial effort has been
focused on the attenuation of interbacterial interactions,
with promising results in many cases. Although still in its
infancy, this analysis provides new tools which, in combi-
nation with other therapeutic measures including symbi-
otic therapy, phage therapy, and the use of polybacterial
vaccines, could facilitate improved therapeutic approaches
to prevent and treat polybacterial infection [1]. Although
the strategies outlined above present attractive solutions,
many challenges exist in developing effective treatments
targeting interbacterial interactions exclusively, including
obstacles in specificity and delivery of the treatment, po-
tential negative implications of systemic inhibition, and
knock-on effects on normal flora. Despite advances in
developing animal models for polymicrobial disease, the
in vivo efficacy of most of these approaches remains to be
assessed (Box 1).
Concluding remarks
It is now clear that many infections are polybacterial in
nature, and that interactions between different organisms
can contribute to disease progress and clinical outcome.
These interactions may involve commensal bacteria as well
as pathogens and are mediated by a range of molecular
mechanisms that include interspecies signaling, metabo-
lite exchange, and cell–cell contact. The consequences of
interaction are often modulation of pathogen behavior
including alterations in virulence factor synthesis, biofilm
formation, and antibiotic resistance or tolerance. More
research is needed to provide a better mechanistic insight
into the complex interplay between potential pathogenic
agents, commensal organisms, and their eukaryotic hosts
(Box 3). Understanding the molecular basis and biological
effect of these interbacterial processes may lead to an
improvement of treatment regimens and also define new
targets and strategies for disease control.
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